Latest Breaking News On - ப்ராடக்ட் பண்புகள் - Page 10 : vimarsana.com

Hansa Biopharma announces decision by Swedish New Therapies Council to recommend use of Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Hansa Biopharma announces decision by Swedish New Therapies Council to recommend use of Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUppsala lanHansa biopharmaPrnewswire hansa biopharmaKlaus sindahlKatja margellSwedish new theraphies councilSwedish kidney associationSwedish new therapies councilEuropean unionEuropean union memberEuropean medicines agencyEuropean medicines agency ema priorityHead of corporate communicationsNasdaq stockholmSwedish dental

Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis

Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis - read this article along with other careers information, tips and advice on BioSpace

United statesUnited kingdomCity ofRepublic of irelandLudovic fenauxExchange commissionHuman rights campaignVertex internationalItalian medicines agencyVertex pharmaceuticals incorporated nasdaqPharmaceuticals incorporatedSenior vice presidentCombination withProduct characteristicsInnovation districtNorth america

Vertex Pharmaceuticals Incorporated: Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO, SYMKEVI and Additional Indications of ORKAMBI and KALYDECO for Eligible Patients With Cystic Fibrosis

Vertex Pharmaceuticals Incorporated: Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO, SYMKEVI and Additional Indications of ORKAMBI and KALYDECO for Eligible Patients With Cystic Fibrosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofRepublic of irelandLudovic fenauxExchange commissionHuman rights campaignVertex internationalItalian medicines agencyVertex pharmaceuticals incorporated nasdaqVertex pharmaceuticals incorporatedPharmaceuticals incorporatedSenior vice presidentCombination withProduct characteristicsInnovation district

Genmab Announces that Janssen has Received European

Genmab Announces that Janssen has Received European
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyVolwassenen nederlandKalvebod bryggeMarisol peronStichting hemato oncologieAndrew carlsenJanssen biotech incEuropean commissionExchange commissionScin the european unionGlobal investor relations communicationsAmerican cancer societyCompany announcementEuropean myeloma networkEuropean committee

Santhera Announces Phase 4 LEROS Trial with Raxone® Met Primary Endpoint in Patients with Leber s Hereditary Optic Neuropathy

Santhera Announces Phase 4 LEROS Trial with Raxone® Met Primary Endpoint in Patients with Leber s Hereditary Optic Neuropathy
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesThomas klopstockEva kaliasDario eklundSanthera pharmaceuticalsHead external communicationsSanthera pharmaceuticals holdingUniversity of munichChiesi groupEuropean medicines agencyAccess programNorth americaExpanded access programRaxone summaryProduct characteristics